Commentary: statins and fracture--why the confusion?
Commentary: statins and fracture--why the confusion?
In 1999 a paper published in Science suggested that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) increased bone formation in rodents by effects on a potent bone forming cytokine bone morphogenetic protein-2 (BMP-2).1 Subsequent studies have suggested that statins increase bone mineral density (BMD) in humans2 and have investigated whether statin use is associated with reduced fracture risk.
editorial, nosp, bone
1312-1313
Edwards, C.J.
f3c756df-8b83-4c2a-9e25-bd4820e75d28
Arden, N.K.
23af958d-835c-4d79-be54-4bbe4c68077f
2006
Edwards, C.J.
f3c756df-8b83-4c2a-9e25-bd4820e75d28
Arden, N.K.
23af958d-835c-4d79-be54-4bbe4c68077f
Edwards, C.J. and Arden, N.K.
(2006)
Commentary: statins and fracture--why the confusion?
International Journal of Epidemiology, 35 (5), .
(doi:10.1093/ije/dyl137).
Abstract
In 1999 a paper published in Science suggested that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) increased bone formation in rodents by effects on a potent bone forming cytokine bone morphogenetic protein-2 (BMP-2).1 Subsequent studies have suggested that statins increase bone mineral density (BMD) in humans2 and have investigated whether statin use is associated with reduced fracture risk.
This record has no associated files available for download.
More information
Published date: 2006
Keywords:
editorial, nosp, bone
Identifiers
Local EPrints ID: 61070
URI: http://eprints.soton.ac.uk/id/eprint/61070
ISSN: 0300-5771
PURE UUID: 11ae2f7b-dd29-46a2-b9fe-da853bac21bf
Catalogue record
Date deposited: 08 Sep 2008
Last modified: 15 Mar 2024 11:22
Export record
Altmetrics
Contributors
Author:
C.J. Edwards
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics